The EPDS (Edinburgh Postnatal Depression Scale) is a 10-item self-report scale designed to screen women for symptoms of depression and anxiety during pregnancy and the first year postpartum. Unlike general depression screens, the EPDS is tailored for the perinatal experience, making it a vital tool for obstetricians, midwives, and mental health professionals to identify “at-risk” parents during a vulnerable life transition.

• The Goal: To provide a safe, structured way for new and expecting parents to communicate emotional distress that might otherwise be overlooked.

The EPDS measures the frequency of depressive and anxious symptoms over the past seven days. While it is primarily a depression screen, it is highly sensitive to the anxiety and “overwhelm” that often accompany the transition to parenthood.

• Key Focus: It prioritizes symptoms like inability to laugh, unnecessary self-blame, and feeling “scared or panicky” over physical symptoms like tiredness, which are common in all new parents regardless of their mental health status.

The EPDS is scored by summing the responses to the 10 items, each rated from 0 to 3, for a total score between 0 and 30.

• Reverse Scoring: Several items on the EPDS are “reverse scored” (where 3 represents the lowest distress and 0 the highest).
• Clinical Accuracy: Because of this complexity, using a digital tool like MyOutcomes is recommended to ensure scoring accuracy and to prevent manual calculation errors during a busy clinic visit.

While interpretation can vary by region, two primary thresholds are used to guide clinical next steps:

• Score of 10–12: Suggests “possible” depression; usually warrants a follow-up appointment or repeat screening in 2–4 weeks.
• Score of 13 or higher: Indicates a high probability of a depressive illness; typically requires an immediate clinical interview and referral to a mental health specialist.

Item 10 asks directly about thoughts of self-harm, and any positive response (a score of 1, 2, or 3) requires immediate safety assessment.

1. Safety Protocol: Even if the total score is low (e.g., a total score of 5), a positive response on Item 10 is a “Critical Flag.” Clinicians must conduct a thorough risk assessment and ensure the client’s safety before they leave the office.

No, the EPDS is a screening tool, not a diagnostic instrument. A high score does not mean a person has PPD; it means they are experiencing a level of distress that requires further evaluation. A formal diagnosis must be made by a healthcare provider through a clinical interview that considers the person’s history and functional impairment.

The EPDS is a “specialist” tool for parents, while the PHQ-9 is a “generalist” tool for the broader population.

EPDS Advantage: It excludes physical symptoms like “appetite changes” or “fatigue,” which are often “false positives” in pregnant or postpartum women.

PHQ-9: Better suited for general depression tracking outside of the perinatal window.

Recommendation: For pregnancy and the first year after birth, the EPDS is the clinically preferred measure worldwide.

Digital EPDS tracking via MyOutcomes allows for “Waiting Room Screening,” where the client completes the scale on a tablet before seeing the provider. This ensures that “Item 10” flags are instantly visible to the clinician, allowing for immediate safety interventions. Furthermore, MyOutcomes can graph EPDS scores across the entire perinatal journey—from the first trimester through the first birthday—allowing clinicians to see if a mother’s “distress curve” is improving or if a change in the treatment plan is needed to support both the parent and the developing child.